Cargando…

Rituximab and Cytokine Release Syndrome

Rituximab is a biologic agent that is usually well tolerated. With its increasing use for a myriad of rheumatologic and immunologic conditions, post-marketing surveillance has revealed more side effects. Systemic inflammatory response syndrome associated with cytokine release syndrome (CRS) is a ver...

Descripción completa

Detalles Bibliográficos
Autores principales: Kulkarni, Hrishikesh S., Kasi, Pashtoon Murtaza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3364040/
https://www.ncbi.nlm.nih.gov/pubmed/22666201
http://dx.doi.org/10.1159/000337577